Professional
Added to YB: 2025-01-30
Pitch date: 2025-01-24
ICLR [bullish]
ICON Public Limited Company
-9.89%
current return
Author Info
No bio for this author
Company Info
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
Market Cap
$12.6B
Pitch Price
$202.48
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.01
P/E
22.02
EV/Sales
1.93
Sector
Life Sciences Tools and Services
Category
growth
Sequoia Strategy Composite New Position: ICON Public Limited Company
ICLR: Top CRO running clinical trials for pharma. Industry growing faster than pharma spend. 50% outsourcing potential. Recent weakness from 2 large customers, biotech funding, & pharma spend. Down 47% from highs. Long-term fundamentals intact. Scaled player in promising drug development landscape.
Read full article (2 min)